Proactive Investors Interview – Algernon Pharmaceuticals files a pre-IND meeting request with US FDA for Ifenprodil Small Cell Lung Cancer Study
Algernon Pharmaceuticals is a clinical stage pharmaceutical development company.
Sign up for our News Releases and Updates
Head Office
Suite 400 - 601 West Broadway
Vancouver, British Columbia V5Z 4C2
Vancouver, British Columbia V5Z 4C2